Circadian High Intensity Interval Training Study

NCT ID: NCT03553524

Last Updated: 2022-05-24

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-10-30
• Study Completion Date: 2022-10-30

Brief Summary

High intensity interval training (HIIT) is a promising intervention for treatment and prevention of type 2 diabetes. In spite of the interplay between circadian rhythms and exercise, the time of day in which the most robust adaption to HIIT can be achieved is unknown. The main goal of the study is to compare the efficacy of morning and afternoon HIIT in lowering blood glucose values in participants with type 2 diabetes.

Detailed Description

High intensity interval training (HIIT) is a promising intervention for treatment and prevention of type 2 diabetes. In spite of the interplay between circadian rhythms and exercise, the time of day in which the most robust adaption to HIIT can be achieved is unknown. The main goal of the study is to compare the efficacy of morning and afternoon HIIT in lowering blood glucose values in participants with type 2 diabetes. Additionally, we aim to to elucidate the underlying hormonal changes and fuel utilization preference responsible for the differing blood glucose response.

A randomized cross-over trial with 40 participants with type 2 diabetes will be performed. The participants will be examined on three occasions on an in-patient basis (36-hour hospital visits). On visit 1 baseline (no exercise) measurements will be established. On visit 2 the participants will perform a single bout of HIIT either in the morning (08:30) or afternoon (19:30). After a 1-week washout period, the participants will return for visit 3 and an opposing exercise time. Primarily, the efficacy of the morning and afternoon HIIT will be judged by the continuous glucose monitor (CGM) -based glycaemia measurements. Additionally, during the visits the investigators will collect repeated blood samples to assess the effect of exercise timing on the diurnal hormonal rhythms. Fuel utilization preference will be measured by respiratory exchange ratio (RER)during exercise.

The hypothesis is that afternoon HIIT will be more efficacious in controlling blood glucose values, based on the preliminary data gathered from the 'free living' pilot study. The current study will aim to compare the morning and afternoon exercise in controlled conditions, eliminating the effects of dietary intake, medication and sleep cycle disruption. Additionally, the specific factors responsible for the differing glycaemic response to morning and afternoon exercise will be elucidated.

Preliminary data from the pilot study

A randomised cross-over pilot study with 11 participants with type 2 diabetes in 'free living' conditions has been performed. Glycaemia measurements were collected by continuous glucose monitors (CGMs) for 2 weeks pre-training and for the duration of the study. The participants were assigned to either morning (08:00) or afternoon (16:00) training regime consisting of 6 HIIT occasions over 2 weeks. Following a 2-week 'wash-out' period, the participants performed the opposing exercise training regime. The preliminary results show that HIIT is more efficacious in improving glycaemia when performed in the afternoon, rather than in the morning.

This pilot was a field-based study in 'free-living' individuals, thus the specific factors responsible for the differing blood glucose levels between morning and afternoon exercise trials remain to be elucidated. Now is the aim to perform a study in controlled condition, limiting the effects food intake, medication and sleep-wake cycle disruption and measuring the effects of a single HIIT bout on glycaemia. The hypothesis is that HIIT bout at different times of day diversely affects diurnal hormonal rhythms, accounting for the differing glycaemic responses.

Conditions

Type 2 Diabetes; Insulin Independent

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: CROSSOVER
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

Morning first

Both arms of the study will perform the baseline measurements during visit 1. Arm 1 of the study will perform HIIT at 08:30 during visit 2, and after a 1-week washout period will perform HIIT at 19:30 during visit 3.

HIIT bout will consist of 3 minutes of warm-up followed by 6 1-minute intervals of full exertion cycling on a cycle ergometer, interspersed by a 1-minute recovery periods and ending with a 3-minute cooldown.

Group Type: EXPERIMENTAL

morning HIIT --> afternoon HIIT

Intervention Type: OTHER

Arm 1 will start with morning HIIT at visit 2 and afternoon HIIT at visit 3

Afternoon first

Both arms of the study will perform the baseline measurements during visit 1. Arm 2 of the study will perform HIIT at 19:30 during visit 2, and after a 1-week washout period will perform HIIT at 08:30 during visit 3.

HIIT bout will consist of 3 minutes of warm-up followed by 6 1-minute intervals of full exertion cycling on a cycle ergometer, interspersed by a 1-minute recovery periods and ending with a 3-minute cooldown.

Group Type: EXPERIMENTAL

afternoon HIIT --> morning HIIT

Intervention Type: OTHER

Arm 2 will start with afternoon HIIT at visit 2 and morning HIIT at visit 3

Interventions

morning HIIT --> afternoon HIIT

Arm 1 will start with morning HIIT at visit 2 and afternoon HIIT at visit 3

Intervention Type: OTHER

afternoon HIIT --> morning HIIT

Arm 2 will start with afternoon HIIT at visit 2 and morning HIIT at visit 3

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age: 45 - 68 years
• Body Mass Index (BMI): 23 - 33 kg/m2
• Participant diagnosed with Type 2 Diabetes (insulin independent)
• Ability to provide informed consent
• Ability to complete the exercise regiment

Exclusion Criteria

• Medications: Insulin
• Current nicotine user (cigarettes, snus, nicotine gum)
• Past nicotine use less than 6 months before inclusion in the study
• Pre-existing cardiovascular condition: Angina pectoris, Cardiac arrhythmia, Cardiac infarction, Coronary stent / angiography, Cerebrovascular insult, Hypertension
• Pre-existing blood-borne disease: HIV, Hepatitis C, MRSA
• Pre-existing systemic or localized rheumatic illness
• Cancer
• Pre-existing psychiatric disorder
• Another pre-existing systemic disease

• Minimum Eligible Age: 45 Years
• Maximum Eligible Age: 68 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Karolinska Institutet

OTHER

Sponsor Role: lead

Responsible Party

Harriet Wallberg

Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Karolinska Institutet

Stockholm, , Sweden

Countries

Sweden

Other Identifiers

CircHIIT Study

Identifier Type: -

Identifier Source: org_study_id